Winton Group LTD Axogen, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$14.62 - $22.13 $299,037 - $452,647	-20,454 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$17.09 - $38.25 $52,021 - $116,433	3,044 Added 17.48%	20,454 $418,000
Q3 2018 Nov 02, 2018	BUY	$34.05 - $55.9 $106,712 - $175,190	3,134 Added 21.95%	17,410 $0
Q2 2018 Aug 20, 2018	SELL	$36.15 - $52.5 $416,375 - $604,695	-11,518 Reduced 44.65%	14,276 $0
Q1 2018 May 21, 2018	BUY	$24.4 - $40.25 $629,373 - $1.04 Million	25,794 New	25,794 $0

172

36.5M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $759M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.